Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 3 | $82,990 |
| Sells | 78 | $20,599,068 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 03 Jul 2024 17:27 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | OLIVER TRACIE | Chief Commercial Officer | 02 Jul 2024 | Sale | 9,394 | 25.28 | 237,480 | D |
| 06 May 2024 18:04 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | VAKIENER VICTORIA | Director | 02 May 2024 | Sale | 1,799 | 23.31 | 41,935 | D |
| 03 Apr 2024 18:05 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 01 Apr 2024 | Sale | 6,000 | 28.03 | 168,180 | D |
| 20 Mar 2024 19:06 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | LU HONGBO | Director | 20 Mar 2024 | Purchase | 1,000 | 27.5 | 27,500 | D |
| 20 Mar 2024 19:06 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | LU HONGBO | Director | 19 Mar 2024 | Purchase | 1,000 | 28 | 28,000 | D |
| 20 Mar 2024 19:06 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | LU HONGBO | Director | 18 Mar 2024 | Purchase | 1,000 | 27.49 | 27,490 | D |
| 08 Mar 2024 17:54 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | MYSZKOWSKI KENNETH ALLEN | Chief Financial Officer | 06 Mar 2024 | Sale | 40,000 | 35.19 | 1,407,600 | D |
| 02 Feb 2024 17:25 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 31 Jan 2024 | Sale | 19,730 | 32.71 | 645,368 | D |
| 02 Feb 2024 17:25 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 31 Jan 2024 | Sale | 37,769 | 32.16 | 1,214,651 | D |
| 17 Jan 2024 18:32 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 12 Jan 2024 | Sale | 3,702 | 37.37 | 138,344 | D |
| 17 Jan 2024 18:32 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 12 Jan 2024 | Sale | 4,238 | 36.47 | 154,560 | D |
| 16 Jan 2024 18:06 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | GIVEN DOUGLAS B | Director | 11 Jan 2024 | Sale | 1,100 | 38.55 | 42,405 | D |
| 16 Jan 2024 18:06 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | GIVEN DOUGLAS B | Director | 11 Jan 2024 | Sale | 1,811 | 37.76 | 68,383 | D |
| 16 Jan 2024 18:06 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | WADDILL WILLIAM D. | Director | 11 Jan 2024 | Sale | 1,300 | 38.59 | 50,167 | D |
| 16 Jan 2024 18:06 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | WADDILL WILLIAM D. | Director | 11 Jan 2024 | Sale | 2,634 | 37.81 | 99,592 | D |
| 16 Jan 2024 18:06 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | FERRARI MAURO | Director | 11 Jan 2024 | Sale | 1,000 | 38.63 | 38,630 | D |
| 16 Jan 2024 18:06 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | FERRARI MAURO | Director | 11 Jan 2024 | Sale | 2,147 | 37.8 | 81,157 | D |
| 16 Jan 2024 18:06 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | VAKIENER VICTORIA | Director | 11 Jan 2024 | Sale | 1,100 | 38.84 | 42,724 | D |
| 16 Jan 2024 18:06 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | VAKIENER VICTORIA | Director | 11 Jan 2024 | Sale | 3,620 | 37.87 | 137,089 | D |
| 08 Jan 2024 17:17 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | OLIVER TRACIE | Chief Commercial Officer | 05 Jan 2024 | Sale | 74 | 33.89 | 2,508 | D |
| 08 Jan 2024 17:16 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | MYSZKOWSKI KENNETH ALLEN | Chief Financial Officer | 05 Jan 2024 | Sale | 8,904 | 35.65 | 317,428 | D |
| 08 Jan 2024 17:16 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | MYSZKOWSKI KENNETH ALLEN | Chief Financial Officer | 05 Jan 2024 | Sale | 5,800 | 34.97 | 202,826 | D |
| 08 Jan 2024 17:16 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | MYSZKOWSKI KENNETH ALLEN | Chief Financial Officer | 05 Jan 2024 | Sale | 1,400 | 34.04 | 47,656 | D |
| 08 Jan 2024 17:16 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | SAN MARTIN JAVIER | Chief Medical Officer | 05 Jan 2024 | Sale | 4,403 | 35.64 | 156,923 | D |
| 08 Jan 2024 17:16 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | SAN MARTIN JAVIER | Chief Medical Officer | 05 Jan 2024 | Sale | 3,100 | 35.03 | 108,593 | D |
| 08 Jan 2024 17:16 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | SAN MARTIN JAVIER | Chief Medical Officer | 05 Jan 2024 | Sale | 800 | 34.11 | 27,288 | D |
| 05 Jan 2024 20:02 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 05 Jan 2024 | Sale | 10,000 | 35 | 350,000 | D |
| 05 Jan 2024 20:02 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 05 Jan 2024 | Sale | 12,343 | 35.65 | 440,028 | D |
| 05 Jan 2024 20:02 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 05 Jan 2024 | Sale | 8,000 | 34.94 | 279,520 | D |
| 05 Jan 2024 20:02 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 05 Jan 2024 | Sale | 1,800 | 34 | 61,200 | D |
| 05 Jan 2024 20:02 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 03 Jan 2024 | Sale | 500 | 33.3 | 16,650 | D |
| 05 Jan 2024 20:02 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 03 Jan 2024 | Sale | 2,300 | 32.52 | 74,796 | D |
| 05 Jan 2024 20:02 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 03 Jan 2024 | Sale | 3,500 | 31.81 | 111,335 | D |
| 05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 05 Jan 2024 | Sale | 12,741 | 35.65 | 454,217 | D |
| 05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 05 Jan 2024 | Sale | 8,200 | 34.99 | 286,918 | D |
| 05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 04 Jan 2024 | Sale | 1,600 | 32.63 | 52,208 | D |
| 05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 05 Jan 2024 | Sale | 1,900 | 33.99 | 64,581 | D |
| 05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2024 | Sale | 1,700 | 32.65 | 55,505 | D |
| 05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2024 | Sale | 400 | 33.41 | 13,364 | D |
| 05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2024 | Sale | 2,800 | 32.52 | 91,056 | D |
| 05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2024 | Sale | 3,849 | 31.83 | 122,514 | D |
| 04 Jan 2024 17:25 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 02 Jan 2024 | Sale | 5,318 | 31.25 | 166,188 | D |
| 04 Jan 2024 17:25 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 02 Jan 2024 | Sale | 4,634 | 30.74 | 142,449 | D |
| 22 Dec 2023 17:04 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 20 Dec 2023 | Sale | 12,000 | 28.54 | 342,480 | D |
| 22 Nov 2023 14:31 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | SAN MARTIN JAVIER | Chief Medical Officer | 20 Nov 2023 | Sale | 4,942 | 29 | 143,318 | D |
| 22 Nov 2023 14:31 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | SAN MARTIN JAVIER | Chief Medical Officer | 20 Nov 2023 | Sale | 14,758 | 28.73 | 423,997 | D |
| 27 Oct 2023 18:23 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 25 Oct 2023 | Sale | 24,338 | 24.21 | 589,223 | D |
| 02 Oct 2023 17:51 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | VAKIENER VICTORIA | Director | 28 Sep 2023 | Sale | 1,550 | 26.33 | 40,812 | D |
| 20 Sep 2023 18:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 18 Sep 2023 | Sale | 26,232 | 28.27 | 741,579 | D |
| 20 Sep 2023 18:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 18 Sep 2023 | Sale | 31,523 | 28 | 882,644 | D |
| 06 Jul 2023 18:04 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | OLIVER TRACIE | Chief Commercial Officer | 03 Jul 2023 | Sale | 8,925 | 35.31 | 315,142 | D |
| 05 Jul 2023 18:15 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 30 Jun 2023 | Sale | 3,000 | 35.53 | 106,590 | D |
| 29 Jun 2023 18:41 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | MYSZKOWSKI KENNETH ALLEN | Chief Financial Officer | 27 Jun 2023 | Sale | 15,000 | 36.2 | 543,000 | D |
| 08 May 2023 18:29 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | GIVEN DOUGLAS B | Director | 05 May 2023 | Sale | 6,500 | 40.9 | 265,850 | D |
| 05 May 2023 19:04 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 04 May 2023 | Sale | 25,992 | 40.02 | 1,040,200 | D |
| 05 May 2023 19:04 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 04 May 2023 | Sale | 24,008 | 38.97 | 935,592 | D |
| 05 May 2023 19:04 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 03 May 2023 | Sale | 54,928 | 39.14 | 2,149,882 | D |
| 06 Mar 2023 18:04 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | OLUKOTUN ADEOYE Y | Director | 03 Mar 2023 | Sale | 11,350 | 32.65 | 370,578 | D |
| 01 Mar 2023 18:14 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | GIVEN DOUGLAS B | Director | 27 Feb 2023 | Sale | 875 | 32.62 | 28,542 | I |
| 11 Jan 2023 20:23 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | WADDILL WILLIAM D. | Director | 09 Jan 2023 | Sale | 3,200 | 30 | 96,000 | D |
| 06 Jan 2023 19:30 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 05 Jan 2023 | Sale | 7,500 | 37.39 | 280,425 | D |
| 06 Jan 2023 19:30 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 05 Jan 2023 | Sale | 7,500 | 37.39 | 280,425 | D |
| 06 Jan 2023 19:24 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 05 Jan 2023 | Sale | 6,573 | 37.4 | 245,830 | D |
| 06 Jan 2023 19:24 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 05 Jan 2023 | Sale | 7,230 | 37.4 | 270,402 | D |
| 05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 270 | 40.53 | 10,943 | D |
| 05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 300 | 39.55 | 11,865 | D |
| 05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 5,286 | 38.58 | 203,934 | D |
| 05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 2,894 | 37.58 | 108,757 | D |
| 05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 70 | 40.8 | 2,856 | D |
| 05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 500 | 39.74 | 19,870 | D |
| 05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 5,527 | 38.54 | 213,011 | D |
| 05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 2,653 | 37.53 | 99,567 | D |
| 05 Jan 2023 19:05 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 03 Jan 2023 | Sale | 247 | 40.52 | 10,008 | D |
| 05 Jan 2023 19:05 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 03 Jan 2023 | Sale | 300 | 39.56 | 11,868 | D |
| 05 Jan 2023 19:05 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 03 Jan 2023 | Sale | 3,682 | 38.52 | 141,831 | D |
| 05 Jan 2023 19:05 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 03 Jan 2023 | Sale | 1,642 | 37.49 | 61,559 | D |
| 05 Jan 2023 19:05 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 03 Jan 2023 | Sale | 136 | 40.54 | 5,513 | D |
| 05 Jan 2023 19:05 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 03 Jan 2023 | Sale | 300 | 39.74 | 11,922 | D |
| 05 Jan 2023 19:05 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 03 Jan 2023 | Sale | 2,837 | 38.53 | 109,310 | D |
| 05 Jan 2023 19:05 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | HAMILTON JAMES C | Chief Discovery/Trans Medicine | 03 Jan 2023 | Sale | 1,194 | 37.46 | 44,727 | D |
| 30 Dec 2022 17:12 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | MYSZKOWSKI KENNETH ALLEN | Chief Financial Officer | 29 Dec 2022 | Sale | 30,625 | 40 | 1,225,000 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)